Title : Repaglinide in the management of new-onset diabetes mellitus after renal transplantation.

Pub. Date : 2006 Apr

PMID : 16539642






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The purpose of this study was to investigate the use of the short-acting insulin secretion drug repaglinide in new-onset diabetes mellitus (NODM) after renal transplantation. repaglinide insulin Homo sapiens